Hvis patienterne udvikler nye krampetyper og/ eller oplever en øget hyppighed af status epilepticus, som er forskellig fra patientens basistilstand, bør forholdet mellem fordele og ulemper ved behandlingen revurderes.
If patients develop new seizure types and/ or experience an increased frequency of status epilepticus that is different from the patient ’ s baseline condition, then the benefit risk ratio of the therapy should be reassessed.